NCT00566891View on ClinicalTrials.gov

Safety of High-dose Tirofiban During Coronary Angioplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

February 28, 2009

Conditions
Coronary Artery Disease
Interventions
DRUG

tirofiban

tirofiban high dose bolus 25µ/Kg

DRUG

Clopidogrel

Trial Locations (1)

88100

S Anna Hospital, Catanzaro

All Listed Sponsors
lead

S. Anna Hospital

OTHER

NCT00566891 - Safety of High-dose Tirofiban During Coronary Angioplasty | Biotech Hunter | Biotech Hunter